Lepu Medical | Briefing, News, Analysis, Research, Data

Lepu Medical

Engaged in the R&D, production and sales of cardiovascular disease plant intervention diagnosis and treatment equipment and cardiovascular drugs.

Lepu Medical, founded in June, 1999 and headquartered in Beijing, is an enterprise engaged in the R&D, production and sales of cardiovascular drugs and cardiovascular disease plant interventional diagnosis and treatment equipment . The founder is Pu Zhongjie. Listed on the SZSE on October 30, 2009, the company's major shareholders are Luoyang Ship Material Research Institute, Pu Zhongjie and WP Medical Technologies, INC. Rivals that have direct and indirect competition with Lepu Medical include Peijia, Kintor, Aprea Therapeutics, Viela, etc.

Sector

Healthcare

Industry

Healthcare Services

Sub-industry

Medical Equipment

Founded

Jun 11, 1999

HQ location

Beijing, China

Legal name

Lepu Medical Technology (Beijing) Co., Ltd.

Website

http://www.lepumedical.com/

Employees

501-1000

All
News
Analysis
Research

Briefing Jan 28, 2023 11:20 AM · Healthcare

YingHe Neuro Raises Over CNY 100 Mn in Angel Round

Briefing Jan 17, 2023 10:36 AM · Healthcare

Medical Equipment Company PowerSite Nets Over CNY 100 Mn in Series B

In-depth

Healthcare

Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis

‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’

Yesterday 02:13 PM

Briefing Jan 13, 2023 11:03 AM · Healthcare

Equipment Company Keyto Nets Over CNY 100 Mn in Series C

Briefing Jan 12, 2023 10:53 AM · Healthcare

IVD Company Bioantibody Nets Over CNY 100 Mn in Series A

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Jan 12, 2023 10:25 AM · Healthcare

Surgical Robot Platform Company KouTech Nets Over USD 10 Mn in Series A+ Round

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing Jun 24, 2022 11:07 AM · Healthcare

"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange

Briefing Jun 24, 2022 10:59 AM · Technology | Healthcare

Herui gene launched the early screening product "quansining" for multiple cancer types, covering six high-risk cancer types

Healthcare

Medical Equipment Company TingSN Nets Over CNY 100 Mn in Series B

The cardiac echocardiography company in China is supposed to compete with global leaders

Jan 29, 2023 11:58 AM

Insight

Healthcare

The Era of Digital Health: Smart Medical Wearable Device as An Important Component

This article introduces smart medical wearable devices in China.

Jan 26, 2023 09:31 AM

Briefing Mar 14, 2022 07:58 AM · Healthcare | Financials

Zhang Wenhong: this wave of epidemic is a cold spring, and spring is bound to come

Briefing Nov 02, 2021 07:58 PM · Technology | Healthcare

Xingang shares: the shareholding ratio of controlling shareholders decreased from 50.16% to 49.13%

Briefing Nov 01, 2021 09:38 PM · Healthcare | Financials

Lepu medical: Wei Zhanjiang, deputy general manager, increased 113600 shares

A clinical medical equipment is ready to use. Image credit: Syed Hussaini/Unspalsh

Healthcare · Analysis

Top 10 Market Cap Chinese Medical Device Companies: Champions and Runners-Up

In a recent boom in the Chinese A-share market, the medical device segment has shown a surprising performance, proving its investability and growth potential.

Jul 12, 2020 10:52 AM

A woman works in a lab. Photo courtesy of jarmaluk on Pixabay

Healthcare

USD 130 Million Series A Financing Fuels Lepu Biotech

Lepu Biotech announced Series A financing of CNY 900 million. Shiyu Capital took the lead in this round. Lepu Biotech has several pipelines for precision treatment and targeted therapy for solid tumors.

Jul 01, 2019 09:51 AM

Briefing Sep 09, 2021 07:53 PM · Technology | Healthcare

Laimei pharmaceutical: 99.0654 million shares held by shareholder Qiu Yu and those acting in concert will be auctioned by the judiciary

Briefing Jul 20, 2021 07:03 PM · Healthcare

State Affairs Office: revise and issue the negative list of market access (2021 version) before the end of the year to carry out the pilot of relaxing market access

Briefing Jun 22, 2021 07:58 PM · Healthcare | Automotive

Le Pu medical: New Coronavirus (SARS-CoV-2) antigen self testing kit was awarded CE certification by EU

Briefing Updated 1 hour ago · Healthcare

Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn

EqualOcean Analysis